All posts by: Michael Zand

About Michael Zand

ACEA Bio, Memorial Sloan Kettering Collaborate on CAR T Cell Assay – 360Dx (subscription)

Continue reading

2017-06-05 NEWS

ACEA Bio, Memorial Sloan Kettering Collaborate on CAR T Cell Assay
360Dx (subscription)
They also will evaluate ACEA’s xCelligence Real-Time Cell Analysis platform to monitor destruction of cancer cells by patients’ own genetically modified CAR T cells. ACEA’s instrument can monitor this cancer-killing process in real-time without the use

Continue reading

2017-06-05 NEWS

WPSU

CRISPR, Five Ways
WPSU
CRISPR, which stands for Clustered Regularly Interspaced Short Palindromic Repeats, is the basis for a revolutionary genome-editing technology that allows researchers to make very precise modifications to DNA. The implications are enormous — not only …

and more »

Continue reading

2017-06-05 NEWS

CRISPR genome editing may cause unintended mutations
BioNews
Until now, ‘off-target effects’ of the CRISPR/Cas9 system were thought to be minimal, with improvements to the technique reducing errors to nearly undetectable levels. However, now a new study suggests previous methods for detecting off-target

Continue reading

2017-06-05 NEWS

CRISPR may introduce hundreds of unwanted mutations into the genome, a small study finds.
BioNews
Until now, ‘off-target effects’ of the CRISPR/Cas9 system were thought to be minimal, with improvements to the technique reducing errors to nearly undetectable levels. However, now a new study suggests previous methods for detecting off-target

Continue reading

2017-06-05 NEWS

CRISPR, Five Ways
WBAA
CRISPR, which stands for Clustered Regularly Interspaced Short Palindromic Repeats, is the basis for a revolutionary genome-editing technology that allows researchers to make very precise modifications to DNA. The implications are enormous — not only …

and more »

Continue reading

2017-06-05 NEWS

FierceBiotech

CAR T-Cell therapy sends multiple myeloma into lasting remission
EurekAlert (press release)
“While it’s still early, these data are a strong sign that CAR T-cell therapy can send multiple myeloma into remission,” said ASCO Expert Michael S. Sabel, MD, FACS. “It’s rare to see such high response rates, especially for a hard-to-treat cancer
ASCO dark horse Nanjing Legend Biotech shines with promising CART dataFierceBiotech
Chinese cell therapy effective in small multiple myeloma trialReuters
bluebird bio and Celgene Corporation Announce Updated Clinical Results from Ongoing First-in-Human Multicenter …Business Wire (press release)
TheStreet.com –Endpoints News
all 8 news articles »
Continue reading

2017-06-05 NEWS

NPR

CRISPR, Five Ways
NPR
CRISPR, which stands for Clustered Regularly Interspaced Short Palindromic Repeats, is the basis for a revolutionary genome-editing technology that allows researchers to make very precise modifications to DNA. The implications are enormous — not only …

and more »